Pharmacoeconomic analysis of Metoject® in the treatment of rheumatoid arthritis in Spain

Statistics

Análisis farmacoeconómico de Metoject® en el tratamiento de la artritis reumatoide en España

Carlos Crespoa,b,

, Max Brosaa, Jordi Galvánc, Jordi Carbonelld,e, Jordi Maymód,e, José Luis Marencof, Javier del Pino-Montesg, Alberto Alonsoh, Carlos Rodríguezi

a Oblikue Consulting, Barcelona, Spain

b Departamento de Estadística, Universidad de Barcelona, Barcelona, Spain

c Departamento Médico, Laboratorios Gebro Pharma, Barcelona, Spain

d Hospital del Mar, Barcelona, Spain

e Hospital de la Esperanza, Barcelona, Spain

f Hospital Universitario de Valme, Sevilla, Spain

g Hospital Universitario de Salamanca, Salamanca, Spain

h Hospital de Cruces, Bilbao, Spain

i Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas, Spain

Read

6778

Times
was read the article

3333

Total PDF

3445

Total HTML

Share statistics

Article information

ISSN: 21735743
Original language: English

DOI:10.1016/S2173-5743(10)70046-0

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	4	0	4
2025 5	91	69	160
2025 4	56	36	92
2025 3	50	30	80
2025 2	54	30	84
2025 1	43	77	120
2024 12	28	46	74
2024 11	52	77	129
2024 10	34	46	80
2024 9	35	23	58
2024 8	40	42	82
2024 7	40	46	86
2024 6	31	30	61
2024 5	40	40	80
2024 4	30	20	50
2024 3	34	38	72
2024 2	32	27	59
2024 1	21	24	45
2023 12	18	30	48
2023 11	19	24	43
2023 10	33	29	62
2023 9	30	35	65
2023 8	19	16	35
2023 7	24	26	50
2023 6	22	24	46
2023 5	18	14	32
2023 4	19	9	28
2023 3	31	38	69
2023 2	19	39	58
2023 1	19	31	50
2022 12	29	51	80
2022 11	24	36	60
2022 10	25	24	49
2022 9	23	36	59
2022 8	25	55	80
2022 7	22	50	72
2022 6	25	47	72
2022 5	22	50	72
2022 4	15	43	58
2022 3	25	45	70
2022 2	13	39	52
2022 1	21	57	78
2021 12	25	59	84
2021 11	28	51	79
2021 10	26	58	84
2021 9	26	44	70
2021 8	28	51	79
2021 7	16	30	46
2021 6	25	38	63
2021 5	23	44	67
2021 4	43	92	135
2021 3	54	35	89
2021 2	26	31	57
2021 1	24	25	49
2020 12	24	17	41
2020 11	24	20	44
2020 10	17	13	30
2020 9	24	31	55
2020 8	17	29	46
2020 7	16	19	35
2020 6	25	28	53
2020 5	20	13	33
2020 4	27	10	37
2020 3	16	10	26
2020 2	2	0	2
2020 1	4	0	4
2019 9	4	0	4
2019 6	2	0	2
2019 3	2	0	2
2019 1	1	0	1
2018 5	3	1	4
2018 4	26	9	35
2018 3	35	16	51
2018 2	17	8	25
2018 1	26	7	33
2017 12	24	10	34
2017 11	26	5	31
2017 10	31	13	44
2017 9	11	5	16
2017 8	13	9	22
2017 7	18	13	31
2017 6	21	11	32
2017 5	19	14	33
2017 4	11	10	21
2017 3	10	9	19
2017 2	9	11	20
2017 1	10	11	21
2016 12	32	22	54
2016 11	17	1	18
2016 10	23	7	30
2016 9	29	8	37
2016 8	18	3	21
2016 7	17	6	23
2016 6	1	8	9
2016 5	0	6	6
2016 4	0	9	9
2016 3	1	3	4
2016 2	2	12	14
2016 1	4	7	11
2015 12	3	12	15
2015 11	4	4	8
2015 10	5	12	17
2015 9	3	0	3
2015 8	2	9	11
2015 7	25	4	29
2015 6	33	21	54
2015 5	52	14	66
2015 4	38	32	70
2015 3	28	26	54
2015 2	42	17	59
2015 1	43	15	58
2014 12	44	22	66
2014 11	21	20	41
2014 10	27	20	47
2014 9	36	19	55
2014 8	29	19	48
2014 7	28	28	56
2014 6	47	20	67
2014 5	60	27	87
2014 4	49	16	65
2014 3	47	25	72
2014 2	32	26	58
2014 1	33	20	53
2013 12	26	20	46
2013 11	25	24	49
2013 10	26	20	46
2013 9	29	34	63
2013 8	35	24	59
2013 7	20	25	45
2013 6	35	23	58
2013 5	26	34	60
2013 4	16	22	38
2013 3	30	18	48
2013 2	20	32	52
2013 1	15	22	37
2012 12	23	21	44
2012 11	8	21	29
2012 10	5	11	16
2012 9	7	3	10
2012 6	3	0	3
2012 4	5	0	5
2012 3	4	0	4
2012 2	2	0	2
2012 1	2	0	2
2011 12	3	0	3
2011 11	5	0	5
2011 10	4	0	4
2011 9	2	0	2
2011 8	2	0	2
2011 6	2	0	2
2011 5	3	0	3
2011 4	2	0	2
2011 3	4	0	4
2011 2	8	0	8
2011 1	10	0	10
2010 12	4	0	4
2010 11	14	0	14
2010 10	11	0	11

Show all

Indexed in:

Follow us:

Subscribe:

Statistics

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter